The automated bone scan index (aBSI) has been validated as an independent predictor of overall survival (OS) in metastatic castrate-resistant prostate cancer (mCRPC)
All news from Anaesthesiology
Scientists are indicating that children in Burkina Faso who were vaccinated against group A meningococcal meningitis and septicemia (MenA) between the ages of 1-4 years in 2010, could need a booster dose of the vaccine as early as this year to ensure they remain protected.
Scientists have discovered that some treatments for cancer and sickle cell disease can destroy the germ cells that go on to develop into sperm in the testes of young boys.
Using a manmade version of a human antibody to directly deliver a drug that inhibits a powerful driver of inflammation, can reverse a disease course that often leads to kidney failure and dialysis, investigators report
A new and first of its kind database has been launched listing compounds that could be used to develop new antibiotics in a bid to tackle the global issue of antimicrobial resistance (AMR). The study results are published in the Journal of Antimicrobial Chemotherapy.
A Long Island patient has become the first in the Northeast to have a small, experimental device implanted in the upper thigh to control aggressively high blood pressure, doctors at the Northwell Health system said.
The novel treatment involves a tiny experimental device called the ROX Coupler, which is slightly smaller than a paper clip but is designed to take on the titanic task of controlling a form of hypertension that defies attempts to lower blood pressure by using drugs, diet, and exercise.
The study evaluated the utility of Banyan BTI™, a diagnostic blood test, to rule out the need for a CT scan in patients with a suspected mild TBI, or concussion, presenting to the emergency department within 12 hours of head injury.
After 10 years of research, a Rutgers-led team of scientists has identified two molecules that protect nerve cells after a traumatic brain injury and could lead to new drug treatments
New research shows more promise for using AIDS treatment drugs as a prevention tool, to help keep uninfected people from catching HIV during sex with a partner who has the virus.
Researchers reveal fascinating insights into how people use small doses of psychedelic drugs for therapeutic effects. Microdosing is the practice of taking drugs like LSD or psilocybin (the key ingredient in "magic mushrooms") in amounts too small to produce a "high" but are anecdotally reported to quell anxiety, boost mood, or improve focus and creativity.
Because the drugs are illegal in many jurisdictions, microdosing remains an underground practice and, until recently, was not subject to close scientific investigation. That has changed with a new study that examines how and why people microdose and the reported effects of the practice. According to study co-author Thomas Anderson, it is the first study of its kind.
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorization for Darzalex® (daratumumab).
Background Patient acceptance is an important factor when implementing imaging methods in clinical practice in line with availability, diagnostic accuracy, and cost-effectiveness